Approved for INDICATIONS AND USAGE Cortifoam ® is indicated as adjunctive therapy in the topical treatment of ulcerative proctitis of the distal portion of the rectum in patients who cannot retain hydrocortisone or other corticosteroid enemas.. CLINICAL PHARMACOLOGY Cortifoam ® provides effective topical administration of an anti-inflammatory corticosteroid as adjunctive therapy of ulcerative…
Loading full data from Know Your Drugs Institute…